152 related articles for article (PubMed ID: 1762084)
1. Pharmacological characterization of serotonin-O-carboxymethyl-glycyl-tyrosinamide, a new selective indolic ligand for 5-hydroxytryptamine (5-HT)1B and 5-HT1D binding sites.
Boulenguez P; Chauveau J; Segu L; Morel A; Delaage M; Lanoir J
J Pharmacol Exp Ther; 1991 Dec; 259(3):1360-5. PubMed ID: 1762084
[TBL] [Abstract][Full Text] [Related]
2. [Synthesis and pharmacological study of radioiodinated serotonin derivative specific of 5-HT1B and 5-HT1D binding sites of the central nervous system].
Segu L; Chauveau J; Boulenguez P; Morel A; Lanoir J; Delaage M
C R Acad Sci III; 1991; 312(13):655-61. PubMed ID: 1913239
[TBL] [Abstract][Full Text] [Related]
3. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
Stratford CA; Tan GL; Hamblin MW; Ciaranello RD
Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
[TBL] [Abstract][Full Text] [Related]
4. A comparative autoradiographic study of 5-HT1D binding sites in human and guinea-pig brain using different radioligands.
Bruinvels AT; Landwehrmeyer B; Probst A; Palacios JM; Hoyer D
Brain Res Mol Brain Res; 1994 Jan; 21(1-2):19-29. PubMed ID: 8164519
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and pharmacological characterization of serotonin-O-carboxymethylglycyl[125I]iodotyrosinamide, a new radioiodinated probe for 5-HT1B and 5-HT1D binding sites.
Boulenguez P; Segu L; Chauveau J; Morel A; Lanoir J; Delaage M
J Neurochem; 1992 Mar; 58(3):951-9. PubMed ID: 1738002
[TBL] [Abstract][Full Text] [Related]
6. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons.
Sheldon PW; Aghajanian GK
Synapse; 1991 Nov; 9(3):208-18. PubMed ID: 1776132
[TBL] [Abstract][Full Text] [Related]
7. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
Massot O; Rousselle JC; Fillion MP; Grimaldi B; Cloëz-Tayarani I; Fugelli A; Prudhomme N; Seguin L; Rousseau B; Plantefol M; Hen R; Fillion G
Mol Pharmacol; 1996 Oct; 50(4):752-62. PubMed ID: 8863819
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
Hamel E; Robert JP; Young AR; MacKenzie ET
J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
[TBL] [Abstract][Full Text] [Related]
9. A new 5-hydroxy-indole derivative with preferential affinity for 5-HT1B binding sites.
Boulenguez P; Chauveau J; Segu L; Morel A; Lanoir J; Delaage M
Eur J Pharmacol; 1991 Feb; 194(1):91-8. PubMed ID: 2060597
[TBL] [Abstract][Full Text] [Related]
10. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.
Rinaldi-Carmona M; Congy C; Santucci V; Simiand J; Gautret B; Neliat G; Labeeuw B; Le Fur G; Soubrie P; Breliere JC
J Pharmacol Exp Ther; 1992 Aug; 262(2):759-68. PubMed ID: 1501121
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
13. Tertatolol, a new beta-blocker, is a serotonin (5-hydroxytryptamine1A) receptor antagonist in rat brain.
Prisco S; Cagnotto A; Talone D; De Blasi A; Mennini T; Esposito E
J Pharmacol Exp Ther; 1993 May; 265(2):739-44. PubMed ID: 8496820
[TBL] [Abstract][Full Text] [Related]
14. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
15. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
Hemedah M; Coupar IM; Mitchelson FJ
Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
[TBL] [Abstract][Full Text] [Related]
16. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
17. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
Zhang ZJ; Trivedi BL; de Paulis T; Schmidt DE; Hewlett WA
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
[TBL] [Abstract][Full Text] [Related]
18. Are 5-hydroxytryptamine7 receptors involved in [3H]5-hydroxytryptamine binding to 5-hydroxytryptamine 1nonA-nonB receptors in rat hypothalamus?
Gobbi M; Parotti L; Mennini T
Mol Pharmacol; 1996 Mar; 49(3):556-9. PubMed ID: 8643096
[TBL] [Abstract][Full Text] [Related]
19. 5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin.
Ismaiel AM; Titeler M; Miller KJ; Smith TS; Glennon RA
J Med Chem; 1990 Feb; 33(2):755-8. PubMed ID: 2299641
[TBL] [Abstract][Full Text] [Related]
20. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]